Download Long Term Effects of Chemotherapy

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Long Term Effects of
Chemotherapy
Tracy Sarin, ARNP
Definition
• Late effects: side effects that occur months to years after
treatment
• Issues arise from surgery, radiation, and chemotherapy
Who and Why
• Multidisciplinary
•
•
•
•
•
Primary care providers
Hematology/oncology
Nursing
Physical and/or occupational therapy
Mental health professional
• 2006 IOM report: From Cancer Patient
to Cancer Survivor: Lost in Translation
Cancer Statistics
• In 2014, nearly 14.5 million Americans with a history of cancer
were alive (DeSantis, et al, 2014)
Men
Prostate (43%)
Colorectal (9%)
Melanoma (8%)
Women
Breast (43%)
Endometrial (8%)
Colorectal (8%)
• By 2024, population of cancer survivors will increase to
approximately 19 million people (DeSantis, et al, 2014)
Virtually Every System is
Affected
Head and Neck
• Brain/CNS
•
•
•
•
Hearing changes
Cognitive impairment
Memory issues
Peripheral neuropathy
• Eye
• Cataracts
• Vision change
• Oral health/Dental
• Decreased tooth enamel
• Osteonecrosis of the jaw
Head and Neck
• Offending agents
•
•
•
•
•
•
•
•
•
Vinca alkaloids (vincristine)
Platinums (carbo, cis, oxali
Taxanes (paclitaxel, docetaxel)
Etoposide
Cytarabine—high dose
Ifosfamide—high dose
Methotrexate—high dose
Steroids
Bisphosphonates
Cardiovascular
•
•
•
•
CHF
Hypertension
MI
DVT
• Particularly with hormone treatment
• Edema
• Hyperlipidemia
• Cardiomyopathy
• Biggest offenders
• Anthracyclines and HER2 targeted drugs (doxorubicin,
daunorubicin, traztuzumab, pertuzumab, etc)
Pulmonary
•
•
•
•
Shortness of breath
Decreased lung capacity
Pulmonary fibrosis
Interstitial lung disease
• Offending agents
•
•
•
•
•
Bleomycin (most common)—10%
Carmustine (BCNU) – 20-30% of those getting high dose therapy
Methotrexate – 8%
Alkylating agents (cyclophosphamide, busulfan) - <1%
????? Immunotherapy agents (nivolumab, pembrolizumab,
ipilimumab)????????---stay tuned
GI/GU
•
•
•
•
Digestion
Neuropathy in gut
Chronic bowel changes
Bladder cystitis
• Offending chemotherapies
•
•
•
•
Vinca alkaloids (vincristine)
Cyclophosphamide
Ifosfamide
Platinums (carboplatin, oxaliplatin, cisplatin)
Endocrine
•
•
•
•
•
•
•
•
•
Menopause/ovarian failure
Infertility
Weight gain
Decreased libido
Erectile dysfunction
Hormone deprivation in men
Diabetes
Thyroid dysfunction
Hot flashes
Endocrine
• Treatment causes
•
•
•
•
•
•
•
•
•
•
•
Busulfan
Chlorambucil
Cisplatin
Cyclophosphamide
Nitrogen mustard
Tamoxifen
Aromatase inhibitors (anastarzole, exemestane, letrozole)
Bicalutamide
Leuprolide
Steroids
Ipilumumab
Musculoskeletal
•
•
•
•
•
Osteoporosis
Osteopenia
Increased risk of fracture
Arthralgias
Myalgias
• Offending agents
• Hormone therapy (aromatase inhibitors)
• Steroids
• Chemotherapies inducing menopause
Skin
•
•
•
•
•
Nail changes
Dry skin
Skin discoloration
Sun sensitivity
Radiation recall
• Offenders
•
•
•
•
•
•
Taxanes
5FU
Cyclophosphamide
Doxorubicin
Hydroxyurea
BRAF inhibitors used in melanoma
Bone Marrow/Secondary
Cancers
• Cytopenias
• MDS
• Secondary cancer
•
•
•
•
1-3% of patients develop a new, secondary cancer
Rate is higher in pediatric cancer survivors
ALL in kids--secondary AML
Colorectal cancer--secondary colon/retctal primary or other
digestive organs
• Lung—secondary lung, head/neck, and GU
• Melanoma—additional skin cancers
• Causative agents: doxorubicin,BCNU,
ifosfamide, cytoxan, melphalan, etc.
Emotional
•
•
•
•
•
•
•
Depression
Anxiety
Mood swings
Guilt
Fear of recurrence
Post-traumatic stress disorder
Gratitude
• Financial implications of chemotherapy
FATIGUE
• Most common side effect of cancer treatment
• Offending agents: ALL chemotherapy/hormone
therapy/biotherapy/immunotherapy
What to do, what to do
• Brain/CNS
•
•
•
•
•
Hearing changes—audiology referral
Eye issues— ophthalmology referral, cataract surgery
Oral/dental— diligent dental care
Chemobrain—patience, CBT, neuropsych referral
Peripheral neuropathy
• Assess for functional impairment
• Patience
• Medication management: gabapentin, pregabalin,
duloxetine, amitriptyline, opioids
• PT referral
• Neurology referral
Cardiovascular
• Monitoring
• Check EF during treatment with cardiotoxic drugs
• CHF—swelling, SOA
• DVT—doppler if indicated (particularly in those on hormone
therapy)
• Heart disease/hyperlipidemia
Pulmonary
• Surveillance/monitoring
• Lung disease—refer to pulmonary or managed by PCP
• Immunotherapy—treat with steroids and taper
GI/GU
• Digestion
• Constipation—fiber/laxatives, GI referral
• Diarrhea—loperamide, diphenoxylate with atropine, codeine,
cholestyramine, GI referral
• Neuropathy—motility agents, GI referral
• Bladder cystitis
• Urology referral
Endocrine
• Proactivity/counseling for fertility issues
• AYA program, referral for banking
• Women’s health issues
• Menopause/ovarian failure/dryness/hot flashes
• Avoid herbs/supplements and hormone replacement therapy
• Lubricants
• Assessment of hot flashes
• Venlafaxine, gabapentin, clonidine
• Weight gain
• Exercise, referral to dietitian, support groups
• DM/thyroid
• PCP or endocrinologist
Musculoskeletal
• Bone density testing
• Ca++ with vitamin D
• Weight bearing exercise
• Assistive device if needed, SAFETY FIRST
• PT referral
• Bisphosphonates
Skin
• Emollients
• Protection
• Avoidance
• Sunscreen
• Cover
• Surveillance by PCP
• Dermatology referral
Cytopenias/Secondary cancers
• Investigation
• Anemia, thrombocytopenia, leukopenia
• BMBX necessary?
• Encourage followup
• Follow screening guidelines
Emotional
• Referral
• Counseling
• Support groups
• Medication management
• Antidepressants
• Antianxiety medications
• Financial
• Financial counselor
Fatigue
• Exercise
• PATIENCE
• Treat underlying causes
• Anemia
• Thyroid conditions
• Vitamin D deficiency
• Energy conservation
• Prioritize activities
• Dietary modifications
Case Study
Conclusion
• Population of cancer survivors will only grow
• ASSESS, ASSESS, ASSESS
• Treat or refer
References
• Cancer.Net. (2016). Long-term side effects of cancer treatment. Retrieved August,
2016, http://www.cancer.net/survivorshiplong-term-side-effects-cancer-treatment
• DeSantis, C., Lin, C., Mariotto, A., Siegel, R., et al. (2014). Cancer treatment and
survivorship statistics, 2014. CA: A Cancer Journal for Clinicians, 252-271.
• MDAnderson Cancer Center. (2016). Possible side effects of cancer treatment.
Retrieved, August, 2016, https://www.mdanderson.org/patients-family/life-aftercancer/long-term-effects.html
• Mayo Clinic. (2016). Cancer survivors: Late effects of cancer treatment. Retrieved
August, 2016, http://www.mayoclinic.org/diseases-conditions/cancer/indepth/cancer-survivor/art-20045524
• Oncology Nursing Society. (2014). Red flags in caring for cancer survivors. Retrieved
August, 2016,
https://www.ons.org/sites/default/files/media/Red%20Flags%20for%20Cancer%20Su
rvivors.pdf
• Up to Date. (2016). Long term side effects of chemotherapy. Retrieved August,
2016,
https://www.uptodate.com/contents/search?search=long%20term%20side%20effect
s%20of%20chemotherapy&sp=0&searchType=PLAIN_TEXT&source=USER_INPUT&se
archControl=TOP_PULLDOWN&searchOffset=1&autoComplete=false&language=en&
max=10